Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Heart Rhythm. 2017 Jul 29;14(12):1884–1889. doi: 10.1016/j.hrthm.2017.07.032

Table 1.

Human ANK2 variants linked to in vitro loss-of-function

Variant Domain Phenotype Reference
S646F MBD Long QT, syncope, seizures, dilated cardiomyopathy with SCD, congenital heart defect, Wolff-Parkinson-White syndrome 38
R990Q SBD Long QT, syncope, ventricular fibrillation, sudden cardiac arrest 39
E1425G SBD Long QT, sinus node bradycardia, CPVT, atrial fibrillation, polyphasic t-waves, SCD 22
V1516D DD Atrial fibrillation, exercise-induced VT, drug-induced long QT, syncope, Brugada syndrome, bradycardia, CPVT 40
T1626N CTD Long QT, sinus arrhythmia, syncope, SCD 14
R1788W CTD Long QT, bradycardia, syncope, supraventricular and ventricular arrhythmias 14

MBD, membrane-binding domain; SBD, spectrin-binding domain; DD, death domain; CTD, C-terminal domain; SCD, sudden cardiac death; CPVT, catecholaminergic polymorphic ventricular tachycardia